Tumor-Specific T Cell Activation in Malignant Brain Tumors.
Mohme M, Neidert MC.
Front Immunol. 2020 Feb 13;11:205. doi: 10.3389/fimmu.2020.00205. eCollection 2020.
Characteristics of malignant brain tumor-associated epileptic spasms.
Yamada N, Kuki I, Fukuoka M, Nukui M, Inoue T, Umaba R, Kunihiro N, Yamasaki K, Uda T, Fujisaki H, Okazaki S.
Epileptic Disord. 2024 Aug;26(4):514-519. doi: 10.1002/epd2.20240. Epub 2024 Jun 18.
Glioblastoma: Overview of Disease and Treatment.
Davis ME.
Clin J Oncol Nurs. 2016 Oct 1;20(5 Suppl):S2-8. doi: 10.1188/16.CJON.S1.2-8.
The curse of blood-brain barrier and blood-tumor barrier in malignant brain tumor treatment.
Kawauchi D, Narita Y.
Int J Clin Oncol. 2025 Jul;30(7):1276-1286. doi: 10.1007/s10147-025-02777-3. Epub 2025 May 8.
The definition of primary and secondary glioblastoma.
Ohgaki H, Kleihues P.
Clin Cancer Res. 2013 Feb 15;19(4):764-72. doi: 10.1158/1078-0432.CCR-12-3002. Epub 2012 Dec 3.
[Medical Treatments for Malignant Brain Tumor].
Kitamura Y, Toda M.
Brain Nerve. 2023 May;75(5):561-566. doi: 10.11477/mf.1416202379.
[Malignant brain tumor].
Nomura K.
No To Shinkei. 1996 May;48(5):403-8.
Wants and needs for involvement reported by relatives of patients with a malignant brain tumor: a scoping review.
Guldager R, Nordentoft S, Poulsen I, Aadal L, Loft MI.
JBI Evid Synth. 2023 Nov 1;21(11):2188-2210. doi: 10.11124/JBIES-22-00311.
Malignant brain tumor.
[No authors listed]
JAMA. 1969 Feb 24;207(8):1510.
Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy.
Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG.
Expert Rev Clin Pharmacol. 2012 Mar;5(2):173-86. doi: 10.1586/ecp.12.1.
